Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Atherosclerosis
|
May 15, 2010
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
Menno Vergeer, Danny M Cohn, S Matthijs Boekholdt, et al.
Clinical and Translational Allergy
|
September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The New England Journal of Medicine
|
September 3, 2020
Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
Danny M Cohn, Nicholas J Viney, Lauré M Fijen, et al.
Thrombosis Research
|
October 5, 2013
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL
Josien van Es, Paul L den Exter, Ad A Kaptein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 17, 2025
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Allergy
|
March 14, 2026
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus Results
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Allergy
|
November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema
Remy S Petersen, Laura Bordone, Marc A Riedl, et al.
The New England Journal of Medicine
|
October 24, 2024
CRISPR-Based Therapy for Hereditary Angioedema
Danny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
The New England Journal of Medicine
|
May 31, 2024
Efficacy and Safety of Donidalorsen for Hereditary Angioedema
Marc A Riedl, Raffi Tachdjian, William R Lumry, et al.
The New England Journal of Medicine
|
March 16, 2022
Inhibition of Prekallikrein for Hereditary Angioedema
Lauré M Fijen, Marc A Riedl, Laura Bordone, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Atherosclerosis
|
May 15, 2010
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
Menno Vergeer, Danny M Cohn, S Matthijs Boekholdt, et al.
Clinical and Translational Allergy
|
September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The New England Journal of Medicine
|
September 3, 2020
Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
Danny M Cohn, Nicholas J Viney, Lauré M Fijen, et al.
Thrombosis Research
|
October 5, 2013
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL
Josien van Es, Paul L den Exter, Ad A Kaptein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 17, 2025
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Allergy
|
March 14, 2026
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus Results
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Allergy
|
November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema
Remy S Petersen, Laura Bordone, Marc A Riedl, et al.
The New England Journal of Medicine
|
October 24, 2024
CRISPR-Based Therapy for Hereditary Angioedema
Danny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
The New England Journal of Medicine
|
May 31, 2024
Efficacy and Safety of Donidalorsen for Hereditary Angioedema
Marc A Riedl, Raffi Tachdjian, William R Lumry, et al.
The New England Journal of Medicine
|
March 16, 2022
Inhibition of Prekallikrein for Hereditary Angioedema
Lauré M Fijen, Marc A Riedl, Laura Bordone, et al.
Page
of 9